An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression (Q35928567)

11 August 2017

An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression (English)

1 reference

11 August 2017

1 reference

10

Wayne C Drevets

0 references

Rodrigo Machado-Vieira

object named as

Rodrigo Machado-Vieira

5

0 references

Carlos A Zarate Jr

11

object named as

Carlos A Zarate

1 reference

11 August 2017

7

Lobna A Ibrahim

1 reference

11 August 2017

Giacomo Salvadore

1

1 reference

11 August 2017

Jan Willem van der Veen

2

1 reference

11 August 2017

Yan Zhang

3

1 reference

11 August 2017

Stefano Marenco

4

1 reference

11 August 2017

Jacqueline Baumann

6

1 reference

11 August 2017

David A Luckenbaugh

8

1 reference

11 August 2017

Jun Shen

9

1 reference

11 August 2017

1 November 2011

1 reference

The International Journal of Neuropsychopharmacology

11 August 2017

1 reference

11 August 2017

15

1 reference

11 August 2017

8

1 reference

11 August 2017

1063-1072

1 reference

Signaling pathways underlying the rapid antidepressant actions of ketamine

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Applications of multi-nuclear magnetic resonance spectroscopy at 7T.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Glutamate-based antidepressants: 20 years on.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Neurocircuitry of mood disorders

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Prefrontal cortical gamma-aminobutyric Acid levels in panic disorder determined by proton magnetic resonance spectroscopy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Correction of frequency and phase variations induced by eddy currents in localized spectroscopy with multiple echo times

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Gliogenesis and glial pathology in depression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

An open-label trial of riluzole in patients with treatment-resistant major depression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Does glutamate image your thoughts?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

A New Depression Scale Designed to be Sensitive to Change

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Glutamine Synthetase: Glial Localization in Brain

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

Glutamine synthetase immunoreactivity is present in oligodendroglia of various regions of the central nervous system.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342437

The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.

11 July 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Riluzole augmentation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Measurement of brain glutamate using TE-averaged PRESS at 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001593

Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22040773

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1017/S1461145711001593

1 reference

11 August 2017

1 reference

11 August 2017

1 reference